Scinai Immunotherapeutics (SCNI) Net Income (QoQ) (2014 - 2025)
Scinai Immunotherapeutics (SCNI) Net Income (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - |
| 10 | Scinai Immunotherapeutics | 3.74 Bn | 627.11 Mn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -39.99% |
| Mar 31, 2025 | 56.88% |
| Dec 31, 2024 | -50.25% |
| Sep 30, 2024 | -136.45% |
| Jun 30, 2024 | 407.55% |
| Mar 31, 2024 | -11.81% |
| Dec 31, 2023 | 83.13% |
| Sep 30, 2023 | -404.28% |
| Jun 30, 2023 | 7.03% |
| Mar 31, 2023 | 117.77% |
| Dec 31, 2022 | -222.21% |
| Sep 30, 2022 | -104.87% |
| Jun 30, 2022 | -100.27% |
| Mar 31, 2022 | -112.08% |
| Dec 31, 2021 | 236.93% |
| Sep 30, 2021 | 24.57% |
| Jun 30, 2021 | -388.31% |
| Mar 31, 2021 | 82.58% |
| Dec 31, 2020 | -125.48% |
| Sep 30, 2020 | 231.77% |